Calcipotriene and Betamethasone Dipropionate
- Product NDC
- 45802-816
- 11-digit product format
- 458020816
- Labeler code
- 45802
- Product ID
- 45802-816_9b7de25a-99a2-4123-b913-ba33289ff5be
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Calcipotriene, Betamethasone Dipropionate
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Application
- ANDA200174
- Marketing category
- ANDA
- Marketing start
- 2020-01-30
- Substance
- BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
- Active strength
- .643; 50 mg/g; ug/g
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Calcipotriene and Betamethasone Dipropionate
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BETAMETHASONE DIPROPIONATE | .643 mg/g |
| CALCIPOTRIENE | 50 ug/g |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 826Y60901U, 143NQ3779B |
| Rxcui | 388525 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dde7b902-54a1-627e-12f1-9e6d244ab88c | Product name | 4 | 20250317 |
| 69b49899-11cf-4f7e-bd0a-7dc93b27311b | Product name | 3 | 20250130 |
| bbdc14c7-d940-43b5-a2f7-36c425991f3c | Product name | 1 | 20240320 |
| 0a2fcc35-464b-9ec2-a622-753662cdd48c | Product name | 3 | 20240216 |
| 6f762601-17ef-4321-8f47-77783d3c4d8b | Product name | 3 | 20231116 |
| 1dbefad7-ab34-69c3-e51a-e7148aa38f70 | Product name | 5 | 20220921 |
| 4d1338f1-f50a-5bb5-4946-11534fdee48f | Product name | 2 | 20210527 |
| 7fea2046-07a9-4bb6-9409-828ac6f1f6df | Product name | 1 | 20210201 |
| f059f1a2-0e64-4839-9a7f-42687c91a44b | Product name | 1 | 20201007 |
| c148aeb5-688c-9b49-a40f-30a41e3595e4 | Product name | 2 | 20180419 |
| 4ea9e4b5-b452-48ad-9b25-b9a4d403405d | Product name | 1 | 20160310 |
| f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6 | Product name | 2 | 20151106 |
| 07737a91-49bd-c707-82e4-7a6a1660aef6 | Product name | 2 | 20150616 |
| 4f07db9b-3707-3e2c-05b5-d7852ba808c4 | Product name | 1 | 20140508 |
| 6f16fc1e-e77d-460f-8810-a12ca121425c | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 45802-816-01 | Calcipotriene and Betamethasone Dipropionate | 100 g in 1 TUBE | OINTMENT | 100 | 7 | |
| 45802-816-01 | Calcipotriene and Betamethasone Dipropionate | 1 in 1 CARTON | OINTMENT | 1 | 7 | |
| 45802-816-96 | Calcipotriene and Betamethasone Dipropionate | 60 g in 1 TUBE | OINTMENT | 60 | 7 | |
| 45802-816-96 | Calcipotriene and Betamethasone Dipropionate | 1 in 1 CARTON | OINTMENT | 1 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 45802-816-01 | GM - Gram | 45802-816 | c25d95df-df73-4465-addb-612ce4688ef7 | 1 | 2020-02-13 |
| 45802-816-96 | GM - Gram | 45802-816 | 838519b1-24cd-4dd6-8b18-9edb1d9df1e3 | 1 | 2020-02-13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 45802-816 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE (CALCIPOTRIENE, BETAMETHASONE DIPROPIONATE) OINTMENT [PADAGIS ISRAEL PHARMACEUTICALS LTD] | 7 | Current NDC, Legacy NDC, 4 package rows | 20241222_ba55ff2b-9cfe-40dc-9dac-718cf141c171.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 388525 | calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Ointment | PSN | 174c5378-f2b9-4e9e-931a-4123137be62d | 103 |
| 388525 | calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Ointment | PSN | d4b301c5-704a-406d-9d9c-74f006334f8a | 103 |
| 388525 | betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment | SCD | 174c5378-f2b9-4e9e-931a-4123137be62d | 103 |
| 388525 | betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment | SCD | d4b301c5-704a-406d-9d9c-74f006334f8a | 103 |
| 388525 | betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Ointment | SY | 174c5378-f2b9-4e9e-931a-4123137be62d | 103 |
| 388525 | betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Ointment | SY | d4b301c5-704a-406d-9d9c-74f006334f8a | 103 |
| 388525 | betamethasone 0.05 % / calcipotriene 0.005 % Topical Ointment | SY | d4b301c5-704a-406d-9d9c-74f006334f8a | 103 |
| 388525 | betamethasone 0.05 % / calcipotriene 0.005 % Topical Ointment | SY | 174c5378-f2b9-4e9e-931a-4123137be62d | 103 |
| 388525 | betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment | SY | d4b301c5-704a-406d-9d9c-74f006334f8a | 103 |
| 388525 | betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment | SY | 174c5378-f2b9-4e9e-931a-4123137be62d | 103 |
| 388525 | calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Ointment | PSN | d223e857-590e-48b9-b33e-1275537a508e | 101 |
| 388525 | betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment | SCD | d223e857-590e-48b9-b33e-1275537a508e | 101 |
| 388525 | betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Ointment | SY | d223e857-590e-48b9-b33e-1275537a508e | 101 |
| 388525 | betamethasone 0.05 % / calcipotriene 0.005 % Topical Ointment | SY | d223e857-590e-48b9-b33e-1275537a508e | 101 |
| 388525 | betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment | SY | d223e857-590e-48b9-b33e-1275537a508e | 101 |
| 388525 | calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Ointment | PSN | ba55ff2b-9cfe-40dc-9dac-718cf141c171 | 7 |
| 388525 | betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment | SCD | ba55ff2b-9cfe-40dc-9dac-718cf141c171 | 7 |
| 388525 | betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Ointment | SY | ba55ff2b-9cfe-40dc-9dac-718cf141c171 | 7 |
| 388525 | betamethasone 0.05 % / calcipotriene 0.005 % Topical Ointment | SY | ba55ff2b-9cfe-40dc-9dac-718cf141c171 | 7 |
| 388525 | betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment | SY | ba55ff2b-9cfe-40dc-9dac-718cf141c171 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 45802-816-01 | 45802081601 | 1 TUBE in 1 CARTON (45802-816-01) / 100 g in 1 TUBE | 1 tube | 2020-01-30 | 0000-00-00 | No | No | Current |
| 45802-816-96 | 45802081696 | 1 TUBE in 1 CARTON (45802-816-96) / 60 g in 1 TUBE | 1 tube | 2020-01-30 | 0000-00-00 | No | No | Current |